← Back to Search

Other

Hyperbaric Oxygen Therapy for Aging (HBOT Trial)

Phase 2 & 3

Waitlist Available

Research Sponsored by TruDiagnostic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up testing will compare baseline with 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying how breathing pure oxygen in a pressurized chamber can improve cell health, reduce inflammation, and slow aging. The goal is to find the best oxygen levels and treatment durations for these benefits. The therapy involves breathing oxygen in a pressurized environment and is associated with anti-inflammatory, antioxidant, and healing properties.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ testing will compare baseline with 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~testing will compare baseline with 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and testing will compare baseline with 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Epigenetic Aging

Secondary study objectives

Neurotrax

Side effects data

From 2018 Phase 2 trial • 20 Patients • NCT02363959

10%

Repeat bronchoscopy due to bleeding during biopsy

100%

80%

60%

40%

20%

Study treatment Arm

Hyperbaric Oxygen, Airway Biopsy

No Hyperbaric Oxygen, Airway Biopsy

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Arm 3: Crossover ArmExperimental Treatment1 Intervention

Patients will have 3 months of no treatment, and then be randomized to receive either high pressure or mild pressure HBOT

Group II: Arm 2: High pressure HBOTExperimental Treatment1 Intervention

"High" pressure HBOT: 100% O2 @ 14 PSI for 100 minutes 3x/week for 6 weeks, 2 weeks off, and then an additional 4 weeks of therapy. Followed by 3 months of no treatment

Group III: Arm 1: Mild pressure HBOTExperimental Treatment1 Intervention

"Mild" pressure HBOT: 100% O2 @ 4.2 PSI for 100 minutes 3x/week for 6 weeks, 2 weeks off, and then an additional 4 weeks of therapy. Followed by 3 months of no treatment

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Hyperbaric Oxygen Therapy

2016

Completed Phase 4

~800

Do I qualify?Apply below to find out